Literature DB >> 33729423

COVID-19 Vaccines vs Variants-Determining How Much Immunity Is Enough.

Rita Rubin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33729423     DOI： 10.1001/jama.2021.3370

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  46 in total

1.  Severe Acute Respiratory Syndrome Coronavirus 2: The Emergence of Important Genetic Variants and Testing Options for Clinical Laboratories.

Authors:  Blake W Buchan; Joseph D Yao
Journal:  Clin Microbiol Newsl       Date:  2021-05-21

2.  A quantitative method to project the probability of the end of an epidemic: Application to the COVID-19 outbreak in Wuhan, 2020.

Authors:  Baoyin Yuan; Rui Liu; Sanyi Tang
Journal:  J Theor Biol       Date:  2022-04-30       Impact factor: 2.405

3.  SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people.

Authors:  Tara M Narowski; Kristin Raphel; Lily E Adams; Jenny Huang; Nadja A Vielot; Ramesh Jadi; Aravinda M de Silva; Ralph S Baric; John E Lafleur; Lakshmanane Premkumar
Journal:  Cell Rep       Date:  2022-01-20       Impact factor: 9.995

Review 4.  Covid-19, Lockdown and Self-Isolation: Evaluation of Deliberate Self-Harm Admissions.

Authors:  Callum Shields; Jack Bernard; Omer Idris Mirza; David Reeves; Adrian Wells; Anthony Heagerty
Journal:  Front Psychiatry       Date:  2021-05-17       Impact factor: 4.157

5.  Anti-SARS-CoV-2 Receptor-Binding Domain Total Antibodies Response in Seropositive and Seronegative Healthcare Workers Undergoing COVID-19 mRNA BNT162b2 Vaccination.

Authors:  Gian Luca Salvagno; Brandon M Henry; Giovanni di Piazza; Laura Pighi; Simone De Nitto; Damiano Bragantini; Gian Luca Gianfilippi; Giuseppe Lippi
Journal:  Diagnostics (Basel)       Date:  2021-05-04

Review 6.  Airborne Coronaviruses: Observations from Veterinary Experience.

Authors:  Paolo Pozzi; Alessio Soggiu; Luigi Bonizzi; Nati Elkin; Alfonso Zecconi
Journal:  Pathogens       Date:  2021-05-19

Review 7.  Thromboembolic Complications of SARS-CoV-2 and Metabolic Derangements: Suggestions from Clinical Practice Evidence to Causative Agents.

Authors:  Francesco Nappi; Adelaide Iervolino; Sanjeet Singh Avtaar Singh
Journal:  Metabolites       Date:  2021-05-25

8.  Atrial Fibrillation in COVID-19: Therapeutic Target or Grave Omen?

Authors:  Hassan Khan; Chirag Barbhaiya
Journal:  Heart Lung Circ       Date:  2021-08       Impact factor: 2.975

Review 9.  Keep out! SARS-CoV-2 entry inhibitors: their role and utility as COVID-19 therapeutics.

Authors:  Lennox Chitsike; Penelope Duerksen-Hughes
Journal:  Virol J       Date:  2021-07-23       Impact factor: 4.099

10.  Tracking SARS-CoV-2 Spike Protein Mutations in the United States (2020/01 - 2021/03) Using a Statistical Learning Strategy.

Authors:  Lue Ping Zhao; Terry P Lybrand; Peter B Gilbert; Thomas R Hawn; Joshua T Schiffer; Leonidas Stamatatos; Thomas H Payne; Lindsay N Carpp; Daniel E Geraghty; Keith R Jerome
Journal:  bioRxiv       Date:  2021-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.